Title of article :
MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: A multicenter, randomized, placebo-controlled phase IIb study
Author/Authors :
Adunsky، نويسنده , , Abraham and Chandler، نويسنده , , Julie and Heyden، نويسنده , , Norman and Lutkiewicz، نويسنده , , Jeannine and Scott، نويسنده , , Boyd B. and Berd، نويسنده , , Yuliya and Liu، نويسنده , , Nancy and Papanicolaou، نويسنده , , Dimitris A.، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2011
Abstract :
Most elderly patients admitted for hip fracture suffer functional decline. Previous studies with MK-0677 in hip fracture patients suggested possible benefits to functional recovery. This is a randomized, double-blind study of 123 elderly hip fracture pati
Keywords :
disability , Ghrelin receptor , Growth hormone , IGF-1 , sarcopenia , Hip Fracture
Journal title :
Archives of Gerontology and Geriatrics
Journal title :
Archives of Gerontology and Geriatrics
